Our findings confirm that Ang1–7 can also modulate the activity of both gelatinases A and B in prostate cancer cells, that MMP-9 activity was upregulated in DU-145 and downregulated in PC3, and that MMP-2 levels were suppressed in LNCaP and PC3 cells. Here, MMP2 is linked to prostate carcinoma.